Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
02/02/2024 18:31
Feb 2 (Reuters) - Neximmune Inc NEXI.O :
* CO & CANTOR FITZGERALD & CO., BTIG, LLC, MUTUALLY AGREED
TO
TERMINATE SALES AGREEMENT & ATM PROGRAM JUNE 2022, EFFECTIVE
IMMEDIATELY
* TO NOT INCUR MATERIAL EARLY TERMINATION PENALTIES IN
CONNECTION
WITH TERMINATION OF THE SALES AGREEMENT AND THE ATM PROGRAM
Source text for Eikon: ID:n0001193125-24-022707
Further company coverage: NEXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting